DNAprint Genomics (DNAG)

[SlopsterSlasher]

Integrating Genetics, Genomics and Biology to Gain Clinical Insights into Cancer
Jeffrey Trent
October 15, 2003
http://www.mcli.dist.maricopa.edu/honors/forum.php?yr=0304&id=2

Jeffrey Trent, Ph.D. is the president and chief scientific officer of the new Translational Genomics Research Institute and scientific director for the International Genomics Consortium in Phoenix, Arizona. Dr. Trent graduated from Arcadia High School and earned a B.A. from Indiana University before receiving a Ph.D. from the University of Arizona.

Dr. Trent was scientific director of the cancer genetics branch and senior investigator and chief of intramural research at the National Human Genome Research Institute in Bethesda, MD. His laboratory focuses on the study of genetic changes related to cancer predisposition and progression. Recently his research has focused on the genetic susceptibility to human prostate cancer. Other work in his laboratory has been focused upon relating the recent advances in both molecular biology and cancer genetics and the valuable tools of the Human Genome Project for the study of human oncogenesis. This has included the development of technologies for analyzing the expression patterns of genes using cDNA microarray technology